Search results
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 21 hours agovaccine developer is also eligible to receive royalties and up to $700 million in milestone revenue...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 15 hours agovaccine has demonstrated strong protection to date, and we will be interested to see if mRNA ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 5 days agoNovavax Reports First Quarter 2024 Financial Results and Operational Highlights PR Newswire GAITHERSBURG, Md., May 10, 2024 Announces co-exclusive licensing agreement with ...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 5 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Novavax Inc (NVAX) (Q1 2024) Earnings Call Transcript Highlights
Guru Focus· 5 days agoThe partnership with Sanofi allows Novavax Inc (NVAX) to leverage Sanofi's extensive global vaccine business expertise, potentially leading to hundreds ...
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses | Invezz
Invezz· 5 days agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the...
Maryland-based Novavax soars on big vaccine deal - WTOP News
WTOP Washington· 5 days agoGaithersburg, Maryland-based Novavax has signed a $1.2 billion licensing agreement with French...
Novavax stock soars 40% on Sanofi partnership By Investing.com
Investing.com· 5 days agoFor the first quarter, Novavax reported a first-quarter loss per share of $1.05, wider than the...
France’s Sanofi in COVID-19 vaccine deal with Novavax
KFGO· 5 days agoPARIS (Reuters) - Sanofi on Friday announced it has reached a licensing agreement with Novavax to...